U.K. blood Dx advances screening for congenital cataracts; Quidel wins FDA nods for infectious disease tests;

> Scientists in the U.K. said they've developed a blood test that could help improve the treatment of congenital cataracts in children. Story

> Quidel ($QDEL) gained FDA clearances for two infectious disease tests that run on Life Technologies' ($LIFE) diagnostics platform. Story

> Researchers are trying to enroll thousands of people in a study to evaluate a blood test designed to detect lung cancer much earlier than usual. Story

> Ganymed Pharmaceuticals gained a CE marking for an in vitro diagnostic test designed to assess levels of a particular biomarker in solid tumors. Item

> Massachusetts company Quanterix says a new study showed its multiplexed single molecule immunoassay technology successfully measured multiple proteins simultaneously at the single molecule level. The advance could help diagnose and treat complex diseases. Item

> The global companion diagnostics market should hit $5.6 billion by 2019, Transparency Market Research concluded in a new report. Item

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.